PartnershipsResearchSymptoms and Treatments DYSKINESIA: An Unwelcome Side Effect Adamas Announces Publication of the Two-Year Phase 3 Open-Label EASE LID 2 Trial of GOCOVRI® for Dyskinesia in Patients with Parkinson’s Disease. Sometimes the dyskinesia…WebmasterFebruary 20, 2020